Celsius (NASDAQ:CELH) Price Target Lowered to $80.00 at B. Riley

Celsius (NASDAQ:CELH) had its price target reduced by B. Riley from $110.00 to $80.00 in a research note published on Monday morning, Benzinga reports. B. Riley currently has a buy rating on the stock. B. Riley also issued estimates for Celsius’ Q2 2024 earnings at $0.21 EPS and Q3 2024 earnings at $0.28 EPS.

Several other analysts have also weighed in on the stock. BNP Paribas began coverage on shares of Celsius in a report on Monday, June 24th. They set an outperform rating and a $87.00 price objective for the company. Jefferies Financial Group dropped their price objective on shares of Celsius from $104.00 to $98.00 and set a buy rating for the company in a report on Thursday, June 13th. Maxim Group lowered their price target on shares of Celsius from $110.00 to $90.00 and set a buy rating for the company in a report on Tuesday, June 18th. Bank of America lowered their price target on shares of Celsius from $84.00 to $60.00 and set a neutral rating for the company in a report on Wednesday, July 10th. Finally, Roth Mkm lowered their price target on shares of Celsius from $87.00 to $75.00 and set a buy rating for the company in a report on Thursday, July 18th. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, Celsius presently has a consensus rating of Moderate Buy and an average price target of $76.51.

Celsius Stock Down 3.9 %

NASDAQ:CELH opened at $45.64 on Monday. The firm has a market cap of $10.64 billion, a PE ratio of 50.15, a price-to-earnings-growth ratio of 1.47 and a beta of 1.90. The company’s 50-day moving average price is $66.51 and its two-hundred day moving average price is $70.31. Celsius has a 12 month low of $45.03 and a 12 month high of $99.62.

Celsius (NASDAQ:CELH) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.07. The company had revenue of $355.70 million during the quarter, compared to analyst estimates of $390.37 million. Celsius had a net margin of 18.63% and a return on equity of 111.29%. The company’s revenue was up 36.9% on a year-over-year basis. During the same quarter last year, the business posted $0.13 earnings per share. On average, research analysts expect that Celsius will post 1.06 EPS for the current fiscal year.

Insider Buying and Selling

In other Celsius news, insider Paul H. Storey sold 1,833 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $75.43, for a total value of $138,263.19. Following the transaction, the insider now owns 41,044 shares of the company’s stock, valued at $3,095,948.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Celsius news, major shareholder William H. Milmoe sold 40,000 shares of the company’s stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $92.95, for a total value of $3,718,000.00. Following the completion of the sale, the insider now owns 226,245 shares of the company’s stock, valued at $21,029,472.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Paul H. Storey sold 1,833 shares of the stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $75.43, for a total transaction of $138,263.19. Following the completion of the sale, the insider now owns 41,044 shares in the company, valued at $3,095,948.92. The disclosure for this sale can be found here. Insiders sold a total of 1,772,617 shares of company stock valued at $107,637,044 over the last three months. Company insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On Celsius

Several institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in Celsius by 183.6% in the fourth quarter. Vanguard Group Inc. now owns 13,746,472 shares of the company’s stock valued at $749,458,000 after acquiring an additional 8,899,873 shares during the period. Wellington Management Group LLP lifted its holdings in shares of Celsius by 212.2% during the 4th quarter. Wellington Management Group LLP now owns 3,393,586 shares of the company’s stock valued at $185,018,000 after purchasing an additional 2,306,598 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Celsius by 424.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 2,793,210 shares of the company’s stock valued at $152,287,000 after purchasing an additional 2,261,046 shares in the last quarter. Eagle Asset Management Inc. lifted its holdings in shares of Celsius by 188.8% during the 4th quarter. Eagle Asset Management Inc. now owns 2,958,771 shares of the company’s stock valued at $161,312,000 after purchasing an additional 1,934,400 shares in the last quarter. Finally, Artisan Partners Limited Partnership bought a new position in shares of Celsius during the 4th quarter valued at about $101,116,000. Institutional investors and hedge funds own 60.95% of the company’s stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.